Unlisted Deals:
×

Capillary Technologies India Limited Annual Report and Financials

Last Traded Price 24.00 + 0.00 %

Capillary Technologies India Limited (Capillary Technologies) Return Comparision with Primex 40 Index

Periods 1 Week 1 Month 3 Months 6 Months 1 Year 3 Years All Time
Primex-40
Capillary Technologies India Limited

Capillary Technologies India Limited Consolidated Balance Sheet (Rs. in Millions)

Particulars

31-03-2025

31-03-2024

Non-current assets

 

 

Property, plant and equipment

34.27

31.21

Goodwill

1,884.98

1,838.44

Other Intangible Assets

1,030.39

1,111.88

Right of use assets

59.84

30.13

Intangible assets under development

-

31.10

Other Financial Assets

256.09

144.79

Deferred tax assets (net)

5.62

6.83

Other tax assets

79.88

43.06

Other Non-Current assets

853.25

821.55

Current assets

 

 

 Investments

-

699.25

Trade Receivables

1,611.21

1,456.51

Cash and cash equivalents

2,140.71

1,806.68

Loans

-

399.99

Other financial assets

33.93

27.70

Other Current assets

396.37

261.56

Total Assets

8,386.54

8,710.68

Equity

 

 

Equity Share capital

146.65

146.46

Other Equity

5,535.82

5,243.06

Non- Current liabilities

 

 

Borrowings

12.82

41.69

Lease Liabilities

32.54

8.01

Other financial liabilities

-

18.53

Provision

80.71

66.11

Deferred tax liabilities (net)

71.04

94.99

Current liabilities

 

 

Borrowings

988.12

729.97

Lease Liabilities

30.78

23.42

Trade Payables

 

 

Total outstanding dues of micro and small enterprises

13.23

73.95

Total outstanding dues of creditors other than above

492.52

654.31

Other financial liabilities

145.39

204.83

Other current liabilities

810.98

1,362.02

Provisions

18.21

19.33

Current tax liabilities (net)

7.73

24.00

Total Equity and Liabilities

8,386.54

8,710.68

Capillary Technologies India Limited Consolidated Profit and Loss Account (Rs. in Millions)

Particulars

31-03-2025

31-03-2024

Revenue from Operation

 

 

Retainership and other services

4,811.05

4,021.29

Installation revenue

1,100.31

746.69

Revenue from campaign services on a principal basis

-

483.02

Revenue from campaign services on an agent basis

71.23

-

Other income

136.10

103.40

Total Revenue

6,118.69

5,354.40

Expenses

 

 

Cost of campaign services

-

417.03

Professional and consultancy expenses

994.93

873.15

Software and server charges

921.85

935.84

Employee Benefits Expenses

2,955.20

2,719.43

Other Expenses

460.98

423.86

Total Expenses

5,332.96

5,369.31

Earnings before interest expense, taxes, depreciation

and amortisation

785.73

(14.91)

Finance costs

77.88

177.08

Depreciation and amortisation expenses

601.03

560.61

Profit/ (loss) before exceptional items and tax from

continuing operations

106.82

(752.60)

Current tax

(12.90)

1.93

Deferred tax credit

(21.82)

(71.02)

Profit/ (loss) for the year from continuing operations

141.54

(683.51)

Profit/ (loss) before tax from discontinued operations

(8.54)

113.58

Tax expense of discontinued operations

0.20

23.85

Profit/ (loss) from discontinued operations after tax

(8.74)

89.73

Profit/ (loss) for the year

132.80

(593.78)

Other comprehensive income

 

 

Items that will be reclassified to profit or loss:

 

 

Exchange differences on translating financial statements

of foreign operations

72.74

63.88

Items that will not to be reclassified to profit or loss:

 

 

Re-measurement losses on defined benefit plan, net of tax

(4.24)

(4.06)

Total comprehensive income/ (loss) for the year

201.30

(533.96)

Earnings/ (loss) per equity share (EPS)

 

 

EPS from continuing operations

 

 

Basic

1.93

(12.15)

Diluted

1.91

(12.15)

EPS from discontinued operations

 

 

Basic

(0.12)

1.59

Diluted

(0.12)

1.57

EPS from continuing and discontinued operations

 

 

Basic

1.81

(10.55)

Diluted

1.79

(10.55)

Capillary Technologies India Limited Consolidated Cash Flow Statement (Rs. in Millions)

Particulars

31-03-2025

31-03-2024

Cash Flow from Operating Activities

 

 

Profit/ (Loss) for the year from continuing operations

before exceptional items and tax

106.82

(752.60)

Profit/ (Loss) for the year from discontinued operations before tax

(8.54)

113.58

Adjustments to reconcile loss before tax to net cash flows

 

 

Depreciation and Amortisation expenses

621.98

582.20

Loss allowances under expected credit loss model

78.42

41.21

Share based payments

80.94

68.84

Profit on sale of investments

(76.53)

(17.55)

Fair value change in financials assets measured at fair value

through statement of profit and loss

-

(9.59)

Interest income on income tax refund

(2.05)

(2.58)

Profit on sale of property, plant and equipment

(0.62)

(0.51)

Property, plant and equipment written off

0.81

2.31

Interest income on corporate deposit

(25.18)

(6.50)

Provision / liabilities no longer required, written back

(0.18)

(26.07)

Unrealised exchange (gain)/ loss on foreign currency

transactions (net)

9.76

(19.23)

Interest income on bank deposits and security deposit

(13.92)

(12.99)

Finance costs

68.53

168.30

Operating Profit/(Loss) before Working Capital Charges

840.24

128.82

Changes in Working Capital

 

 

Increase/ (Decrease) in Trade Receivables

(242.89)

564.87

Increase/ (Decrease) in Other Assets

(166.51)

(948.06)

Increase/ (Decrease) in Other Financial Assets

(12.40)

242.35

Increase/ (Decrease) in Trade Payables

(222.33)

139.69

Increase/ (Decrease) in Provisions

9.24

6.19

(Increase)/ Decrease in Other Financial Liabilities

(77.97)

74.57

(Increase)/ Decrease in Other Liabilities

(551.04)

755.72

Cash flow from/ (Used in) Operating Activities

(423.66)

964.15

Direct taxes (paid) / refund, net

(38.33)

7.20

Net Cash Flow (Used in)/ Generated from

Operating Activates

(461.99)

971.35

Cash Flow from Investing Activities

 

 

Purchase of property, plant and equipment, intangible assets and

intangible assets under development

(474.58)

(369.32)

Proceeds from sale of property, plant and equipment

0.62

2.31

Sale/(Purchase) of current investment, net

775.78

(672.11)

Corporate deposits placed

(400.00)

(399.99)

Proceeds from redemption of corporate deposits

799.99

-

Interest income on bank deposits

13.92

10.14

Interest income on corporate deposits

25.18

0.64

Investment in bank deposits (net)

(105.13)

(29.10)

Payment of acquisition of subsidiary

-

(387.82)

Net Cash Flow (Used in)/ Generated from

Investing Activities

635.78

(1,845.25)

Cash Flow from Financing Activities

 

 

Repayment of Borrowings

49.92

1,337.43

Proceeds from issue of share capital, (including security premium)

-

50.00

Proceeds from issue of Non-Convertible Debentures (NCDs)

(352.48)

(237.89)

Proceeds from issue of Compulsory Convertible Debentures (CCDs)

-

1,701.50

Repayment of long-term borrowings

-

(366.82)

Repayment of principal and interest portion of lease liabilities

(33.04)

(24.23)

Proceeds from short-term borrowings (net)

581.06

4.90

Finance costs paid

(64.62)

(166.91)

Surrender of employee stock options and re-purchase, net

(48.25)

(120.37)

Net Cash Flow (Used in)/ Generated from

Financing Activities

132.59

2,177.61

Net Increase /(Decrease) In Cash and Cash Equivalents

306.38

1,303.71

Cash & Cash Equivalents at the Beginning of the Year

1,806.68

462.00

Effect of exchange differences on cash and cash equivalents

held in foreign currency

27.65

40.97

Cash & Cash Equivalents at the End of the Year

2,140.71

1,806.68

Here is a summary of the Cash Flow Statement for the years 2025 and 2024:

 Cash Flow from Operating Activities

In the year ending 31st March 2025, the company had a net cash outflow of ₹462 million from operating activities, compared to a large inflow of ₹971 million in the previous year. Although the company reported a profit before tax of ₹106.82 million (from continuing operations) and (₹8.54) million (from discontinued operations), this was offset by significant negative changes in working capital especially an increase in other liabilities and a fall in trade payables and receivables.

Cash Flow from Investing Activities

The company reported a positive cash flow of ₹636 million from investing activities in 2025, reversing the previous year 's outflow of ₹1,845 million. This improvement mainly came from net sale of current investments (₹776 million) and redemption of corporate deposits (₹800 million), despite spending ₹475 million on property and equipment and placing new deposits.

Cash Flow from Financing Activities

In 2025, financing activities generated a net inflow of ₹133 million, though this was much lower than the previous year’s strong inflow of ₹2,178 million. Key movements included proceeds from short-term borrowings (₹581 million) and repayments of NCDs (₹352 million). The prior year also had large proceeds from issuing CCDs and share capital.

Net Change in Cash and Cash Equivalents

Overall, the company ended financial year 2025 with a net increase in cash of ₹306 million, leading to a closing cash balance of ₹2,141 million from ₹1,807 million the previous year. This shows improved liquidity at year-end, mainly due to better investing inflows, despite weak operating performance.

Capillary Technologies Annual Report

Capillary Technologies India Limited Annual Report 2024-25

Download

Capillary Technologies India Limited Annual Report 2023-24

Download

Capillary Technologies India Limited Annual Report 2022-23

Download

Capillary Technologies India Limited AR 2021-22

Download
Support Puja Support Ishika Support Purvi

News Alert